Dog · Canis lupus familiaris · typical adult weight 2.00–80.00 kg
Tigilanol Tiglate is used in dog for Non-metastatic cutaneous mast cell tumors. Routes documented in dog: INTRATUMORAL. A typical adult dog weighs 2.00–80.00 kg. ExoticRx lists 1 cited dose rule for Tigilanol Tiglate in dog, drawn from published veterinary references. Verify against current literature before clinical use.
Trade names: Stelfonta
| Route | Dose | Frequency | Duration | Indication | Evidence | Source |
|---|---|---|---|---|---|---|
| INTRATUMORAL | 0 see notes | Single treatment; may repeat once at day 28 | One or two treatments | Non-metastatic cutaneous mast cell tumors | Strong | Plumb's Veterinary Drug Handbook, 9th Ed |
Need the exact dose for your patient?
These ranges are per kg. Enter your dog's weight to get the precise dose and draw-up volume — unit and concentration math done for you.
Activates protein kinase C, disrupting tumor vasculature and causing hemorrhagic necrosis. Also stimulates innate immune response against tumor cells.
Dogs only. For non-metastatic mast cell tumors (cutaneous/SC). Wound at injection site expected — heals by second intention. Sedation/anesthesia required for injection.
Species-specific contraindications and adverse-reaction reports for dog may differ from canine / feline reference data — consult the primary citations listed with each rule.
Why a species-specific page? Tigilanol Tiglate pharmacokinetics differ across species: dose ranges, intervals, and route preferences are not interchangeable. Cross-extrapolation from canine doses is unsafe in dog — the rules above are the citations specific to this species, not generic recommendations.
Sourced from published veterinary references; awaiting credentialed clinical reviewer. See our editorial process. Reference only — not veterinary advice.